º´¿ë±Ý±â: µÎ °³ ÀÌ»óÀÇ ¾à¹°À» °°ÀÌ Åõ¿©ÇßÀ» ¶§ ¿¹»óÇÏÁö ¸øÇÑ ÀÌ»ó¹ÝÀÀÀÌ ³ªÅ¸³ª°Å³ª Ä¡·áÈ¿°úÀÇ »ó½ÇÀ» ÃÊ·¡ÇÏ´Â ¾à¹°.
  
°Ë»ö°á°ú: ÃÑ 30°³ Áß 21 - 34

¸íÀÎÆä´ÏÅäÀÎÁ¤100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°

Á¦Ç°¸í¼ººÐ¸íÁÖ¼ººÐÄÚµåÇ¥ÁØÄÚµåÆǸŻç°í½Ã¹øÈ£¡ãÀû¿ëÀÏ
Á¨º¸¾ßÁ¤_(1Á¤)cobicistat silicon dioxide (as cobicistat)655900ATB625900090±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯)2019013120191217
Á¨º¸¾ßÁ¤_(1Á¤)elvitegravir655900ATB625900090±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯)2019013120191217
Á¨º¸¾ßÁ¤_(1Á¤)emtricitabine655900ATB625900090±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯)2019013120191217
Á¨º¸¾ßÁ¤_(1Á¤)tenofovir alafenamide fumarate (as tenofovir alafenamide)655900ATB625900090±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯)2019013120191217
¸¶ºñ·¿Á¤_(1Á¤)glecaprevir669700ATB624900290Çѱ¹¾Öºêºñ(ÁÖ)2020013020201228
¸¶ºñ·¿Á¤_(1Á¤)pibrentasvir669700ATB624900290Çѱ¹¾Öºêºñ(ÁÖ)2020013020201228
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤)nirmatrelvir703500ATB648903860Çѱ¹È­ÀÌÀÚÁ¦¾à¢ß2021011320211230
ÆŽº·Îºñµå(´Ï¸£¸¶Æ®·¼ºñ¸£, ¸®Å䳪ºñ¸£)_(30Á¤)ritonavir703500ATB648903860Çѱ¹È­ÀÌÀÚÁ¦¾à¢ß2021011320211230
º¸Ä«ºê¸®¾ÆÁ¤30¹Ð¸®±×·¥(Ä«º¸Åױ׶óºñ¸£³ªÆ®·ý)_(31.62mg/1Á¤)cabotegravir sodium (as cabotegravir)707201ATB650003230(ÁÖ)±Û¶ô¼Ò½º¹Ì½ºÅ¬¶óÀÎ2024003020240625
Àη¹ºòĸ½¶(Æäµå¶óƼ´Õ¿°»ê¿°¼öÈ­¹°)_(0.1173g/1ĸ½¶)fedratinib dihydrochloride monohydrate (as fedratinib)708701ACH658700730(À¯)Çѱ¹ºñ¿¥¿¡½ºÁ¦¾à2024003020240625
ÄÉ·»µð¾ÆÁ¤10¹Ð¸®±×·¥(Çdz׷¹³í)_(10mg/1Á¤)finerenone729201ATB641106200¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ)2024003020240625
ÄÉ·»µð¾ÆÁ¤20¹Ð¸®±×·¥(Çdz׷¹³í)_(20mg/1Á¤)finerenone729202ATB641106190¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ)2024003020240625
·ÎºñÅ¥¾ÆÁ¤100¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(0.1g/Á¤)lorlatinib699702ATB648903620Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ)2024003020240625
·ÎºñÅ¥¾ÆÁ¤25¹Ð¸®±×·¥(·Ñ¶óƼ´Õ)_(25mg/Á¤)lorlatinib699701ATB648903610Çѱ¹È­ÀÌÀÚÁ¦¾à(ÁÖ)2024003020240625